Results show Pfizer/BioNTech and Oxford/AstraZeneca jabs are proving highly effective
More than 90% of Britons develop antibodies to coronavirus after having one dose of the AstraZeneca or Pfizer vaccines, and almost 100% do so after their second jab, research shows.
The findings, based on a study of 8,517 people in England and Wales, are the latest evidence to show that the two mainstays of Britain’s vaccine drive are proving highly effective.
